GKB Ophthalmics Ltd. has announced a board meeting on Thursday, August 14, 2025, to approve the financial results for the quarter ended June 30, 2025. This meeting is crucial for investors, offering insight into the company's recent performance. The trading window for designated persons, which closed on July 01, 2025, will reopen 48 hours after these financial results are submitted to the stock exchange. This update highlights an important upcoming financial disclosure and associated trading restrictions.